Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity

SARS-CoV-2 represents an unprecedented public health challenge. While the majority of SARS-CoV-2-infected individuals with mild-to-moderate COVID-19 resolve their infection with few complications, some individuals experience prolonged symptoms lasting for weeks after initial diagnosis. Persistent vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Hengsheng, Wegman, Adam D., Ripich, Kianna, Friberg, Heather, Currier, Jeffrey R., Thomas, Stephen J., Endy, Timothy P., Waickman, Adam T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155927/
https://www.ncbi.nlm.nih.gov/pubmed/34063463
http://dx.doi.org/10.3390/v13050916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155927/
https://www.ncbi.nlm.nih.gov/pubmed/34063463
http://dx.doi.org/10.3390/v13050916

Ejemplares similares